Journal
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
Volume 24, Issue 14, Pages 1601-1617Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09205063.2013.782804
Keywords
segmented polyurethane; chain extender; amino acids; endothelial cell viability; hemocompatibility
Funding
- CONACYT (Mexico) [79371, 123913]
- FOMIX [108160]
- NSF Stem Cell Biomanufacturing IGERT [NSF DGE 0965945]
Ask authors/readers for more resources
Novel biodegradable segmented polyurethanes (SPUs) were synthesized with polycaprolactone diol, 4,4-methylen bis (cyclohexyl isocyanate) (HMDI), and either L-glutathione or its constituent amino acids (L-glutamic acid, L-cysteine and glycine) as chain extenders. Fourier transform infrared spectroscopy analysis revealed the feasibility of obtaining polyurethanes through the presence of NH (Amide II), C-N, C-O, and C=O bands and the absence of NCO band. Differential scanning calorimetry and X-ray diffraction revealed that a semicrystalline polymer (T-m=42-52 degrees C; 2=21.3 degrees and 23 degrees) was obtained in all cases, while dynamic mechanical analysis (DMA) revealed an amorphous phase (T-g=-30 to -36(o)C). These properties, in addition to their high molecular weight, led to high moduli and higher extensibilities when glycine and glutamic acid were used as chain extenders. Clotting times (Lee-White test) and activated partial thromboplastin time determined on these polyurethanes were longer than with glass. In addition, all synthesized SPU exhibited platelet activation indexes below the collagen type I positive control. Human umbilical vein endothelial cells viability was higher in SPUs containing either glycine or cysteine. The obtained results indicate that SPUs that use cysteine as chain extender are promising candidates for cardiovascular applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available